Successful Treatment of an Aggressive Adult T-cell Leukemia/Lymphoma with Strong CD30 Expression Using Brentuximab Vedotin as Combination and Maintenance Therapy

Adult T-cell leukemia/lymphoma (ATL) is a highly aggressive malignant tumor associated with a poor prognosis. We herein report a 63-year-old man who was newly diagnosed with aggressive ATL. He was treated with brentuximab vedotin (BV) plus cyclophosphamide, doxorubicin, and prednisone (A+CHP therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Baba, Yuta, Sakai, Hirotaka, Kabasawa, Nobuyuki, Harada, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017244/
https://www.ncbi.nlm.nih.gov/pubmed/35871596
http://dx.doi.org/10.2169/internalmedicine.9812-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017244/
https://www.ncbi.nlm.nih.gov/pubmed/35871596
http://dx.doi.org/10.2169/internalmedicine.9812-22

Ejemplares similares